BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34985060)

  • 1. Exploration of α/β/γ-peptidomimetics design for BH3 helical domains.
    Shin YH; Yang H
    Chem Commun (Camb); 2022 Jan; 58(7):945-948. PubMed ID: 34985060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulations of pro-apoptotic BH3 peptide helices in aqueous medium: relationship between helix stability and their binding affinities to the anti-apoptotic protein Bcl-X(L).
    Lama D; Sankararamakrishnan R
    J Comput Aided Mol Des; 2011 May; 25(5):413-26. PubMed ID: 21523491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
    Lama D; Sankararamakrishnan R
    Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of Bcl-xL recognition by a BH3-mimetic α/β-peptide generated by sequence-based design.
    Lee EF; Smith BJ; Horne WS; Mayer KN; Evangelista M; Colman PM; Gellman SH; Fairlie WD
    Chembiochem; 2011 Sep; 12(13):2025-32. PubMed ID: 21744457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downsizing the BAD BH3 peptide to small constrained α-helices with improved ligand efficiency.
    Shepherd NE; Harrison RS; Ruiz-Gomez G; Abbenante G; Mason JM; Fairlie DP
    Org Biomol Chem; 2016 Nov; 14(46):10939-10945. PubMed ID: 27819377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Design of BH3-Mimetic Peptide Inhibitors That Can Bind Specifically to Mcl-1 or Bcl-X
    Reddy CN; Manzar N; Ateeq B; Sankararamakrishnan R
    Biochemistry; 2020 Nov; 59(45):4379-4394. PubMed ID: 33146015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
    Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
    J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residue-Based Preorganization of BH3-Derived α/β-Peptides: Modulating Affinity, Selectivity and Proteolytic Susceptibility in α-Helix Mimics.
    Peterson-Kaufman KJ; Haase HS; Boersma MD; Lee EF; Fairlie WD; Gellman SH
    ACS Chem Biol; 2015 Jul; 10(7):1667-75. PubMed ID: 25946900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BH3 domains other than Bim and Bid can directly activate Bax/Bak.
    Du H; Wolf J; Schafer B; Moldoveanu T; Chipuk JE; Kuwana T
    J Biol Chem; 2011 Jan; 286(1):491-501. PubMed ID: 21041309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfono-γ-AApeptides as Helical Mimetics: Crystal Structures and Applications.
    Sang P; Shi Y; Huang B; Xue S; Odom T; Cai J
    Acc Chem Res; 2020 Oct; 53(10):2425-2442. PubMed ID: 32940995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.
    Moroy G; Martin E; Dejaegere A; Stote RH
    J Biol Chem; 2009 Jun; 284(26):17499-511. PubMed ID: 19293158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain.
    Boersma MD; Haase HS; Peterson-Kaufman KJ; Lee EF; Clarke OB; Colman PM; Smith BJ; Horne WS; Fairlie WD; Gellman SH
    J Am Chem Soc; 2012 Jan; 134(1):315-23. PubMed ID: 22040025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mcl-1 and Bcl-x
    Hockings C; Alsop AE; Fennell SC; Lee EF; Fairlie WD; Dewson G; Kluck RM
    Cell Death Differ; 2018 Mar; 25(4):721-734. PubMed ID: 29459767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹H, ¹³C and ¹⁵N chemical shift assignments of unliganded Bcl-xL and its complex with a photoresponsive Bak-derived peptide.
    Wysoczanski P; Mart RJ; Loveridge EJ; Williams C; Whittaker SB; Crump MP; Allemann RK
    Biomol NMR Assign; 2013 Oct; 7(2):187-91. PubMed ID: 22744789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced metabolic stability and protein-binding properties of artificial alpha helices derived from a hydrogen-bond surrogate: application to Bcl-xL.
    Wang D; Liao W; Arora PS
    Angew Chem Int Ed Engl; 2005 Oct; 44(40):6525-9. PubMed ID: 16172999
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-based approach to the design of BakBH3 mimetic peptides with increased helical propensity.
    Delgado-Soler L; Del Mar Orzaez M; Rubio-Martinez J
    J Mol Model; 2013 Oct; 19(10):4305-18. PubMed ID: 23900856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of benzoylurea-derived alpha-helix mimetics targeting the Bcl-x(L)/Bak binding interface.
    Rodriguez JM; Ross NT; Katt WP; Dhar D; Lee GI; Hamilton AD
    ChemMedChem; 2009 Apr; 4(4):649-56. PubMed ID: 19330783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterocyclic alpha-helix mimetics for targeting protein-protein interactions.
    Biros SM; Moisan L; Mann E; Carella A; Zhai D; Reed JC; Rebek J
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4641-5. PubMed ID: 17555961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosubstituted alkenyl amino acids for peptide "stapling".
    Yeo DJ; Warriner SL; Wilson AJ
    Chem Commun (Camb); 2013 Oct; 49(80):9131-3. PubMed ID: 24005767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors.
    Sang P; Zhang M; Shi Y; Li C; Abdulkadir S; Li Q; Ji H; Cai J
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10757-10762. PubMed ID: 31088961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.